• N/A
    Market Cap
  • -29.87%
    1-Year Change
  • Pharmaceutical Retailers
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 72
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Will JD Health's AI Push Pay Off Amid Powerful Rivalry

JD Health reported strong 2025 earnings with 23% revenue growth to 73.4 billion yuan and a record 8.9% net profit margin, driven primarily by online pharmacy sales (83% of revenue). However, the company faces intensifying competition from rivals like Meituan in on-demand drug delivery and from tech companies like Alibaba Health, Ant Group, and Medlinker entering AI-assisted healthcare. JD Health is investing heavily in AI tools including diagnostic chatbots and digital doctors, but investors are pricing in stronger growth potential for competitors.

03/12/2026, 9:54 AM • Benzinga

Peers

Statistics

More
Day Range
$8.42
$8.42
$8.42
1-Year Range
$8.26
$19.45
$8.42
Latest Close$8.42
Change
-$0.47 (-5.53%)
Volume222

Information as of 06/22/2026

Company Profile

ALIBABA HEALTH UNSP/ADR
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Pharmaceutical Retailers

ALIBABA HEALTH UNSP/ADR

Key Executives

  • Difan Shen
  • Mengyue Sheng
  • Yanwu Tu
  • Zhang Hua
  • Yin Rui

Current Ownership Distribution

  • Other806.2M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)